AI-Driven CTA Reconstruction for Intracranial LVO
Recruiting
N/A
Interventional Study
Acute Ischemic Stroke
Artificial Intelligence (AI)
Endovascular Thrombectomy
CT Angiography
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 95
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 174 (estimated)
- Sponsor
- Shanghai Jiao Tong University Affiliated Sixth People's Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Acute ischemic stroke (AIS) caused by intracranial large vessel occlusion (LVO) in the anterior circulation significantly contributes to stroke-related disability and mortality. Recent randomized controlled trials have demonstrated substantial benefits of endovascular thrombectomy (EVT) when patients are appropriately triaged beforehand. However, accurately orienting the 'missed segment' during EV…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Male or Female, 18 years of age or older.
2. Patients who present with signs and/or symptoms concerning acute ischemic stroke.
3. Patients who undergo noncontrast CT and CT angiography imaging.
4. Patients determined to have an intracranial large vessel occlusion (including t…
Contacts